Mahmoud Marwa, Borthwick Gillian M, Hislop Alison A, Arthur Helen M
Institute of Human Genetics, Centre for Life, Newcastle University, Newcastle upon Tyne, UK.
Lab Invest. 2009 Jan;89(1):15-25. doi: 10.1038/labinvest.2008.112. Epub 2008 Nov 17.
Arteriovenous malformations (AVMs) are direct connections between arteries and veins associated with loss of the intervening capillary bed. In the lungs, pulmonary AVMs can result in right to left shunts and severe cyanosis and dyspnoea. However, the cellular and molecular mechanisms underlying AVM formation are poorly understood. One important clue comes from the fact that pulmonary AVMs frequently occur in the familial disease hereditary haemorrhagic telangiectasia (HHT), which is associated with mutations in one of two receptors involved in transforming growth factor-beta family signalling, either endoglin (ENG) or activin receptor-like kinase 1 (ACVRL1, also known as ALK1). To elucidate the potential link between ENG or ACVRL1 deficiency and AVM formation in HHT, we performed a comprehensive study of Acvrl1 and Eng expression in wild-type and Eng-deficient (Eng+/-) mouse lungs using a combination of immunohistochemistry and RT-PCR from laser-microdissected arteries, veins and capillaries. We found that Eng and Acvrl1 have distinct expression profiles in the pulmonary vasculature and are only co-expressed in the distal (pre-capillary) arteries, distal veins and capillaries, consistent with the tendency for pulmonary AVMs to form in the distal pulmonary vessels in HHT. Downstream pSmad1/5/8 activity was found in the distal arteries and was specifically reduced in Eng+/- mice, consistent with previous in vitro data showing that Eng promotes Acvrl1-mediated Smad1/5/8 phosphorylation. Eng was more widely expressed than Acvrl1 in the lungs, as Eng alone was found in pulmonary veins, potentially explaining the increased frequency of AVMs in HHT1 patients. Furthermore, the association of ACVRL1 mutations with a second vascular disease, familial pulmonary artery hypertension, underlines the importance of ACVRL1 expression in the distal arteries that are affected in this disorder.
动静脉畸形(AVM)是动脉与静脉之间的直接连接,伴有中间毛细血管床的缺失。在肺部,肺动静脉畸形可导致右向左分流以及严重的紫绀和呼吸困难。然而,动静脉畸形形成的细胞和分子机制仍知之甚少。一个重要线索来自于这样一个事实,即肺动静脉畸形常发生于家族性疾病遗传性出血性毛细血管扩张症(HHT),该疾病与转化生长因子-β家族信号传导所涉及的两种受体之一的突变有关,这两种受体分别是内皮糖蛋白(ENG)或激活素受体样激酶1(ACVRL1,也称为ALK1)。为了阐明ENG或ACVRL1缺乏与HHT中动静脉畸形形成之间的潜在联系,我们使用免疫组织化学和来自激光显微切割的动脉、静脉和毛细血管的逆转录聚合酶链反应(RT-PCR)相结合的方法,对野生型和ENG缺陷(Eng+/-)小鼠肺中的Acvrl1和Eng表达进行了全面研究。我们发现,Eng和Acvrl1在肺血管系统中具有不同的表达模式,仅在远端(毛细血管前)动脉、远端静脉和毛细血管中共表达,这与HHT中肺动静脉畸形倾向于在远端肺血管中形成的趋势一致。在远端动脉中发现了下游pSmad1/5/8活性,并且在Eng+/-小鼠中特异性降低,这与之前的体外数据一致,即Eng促进Acvrl1介导的Smad1/5/8磷酸化。Eng在肺中的表达比Acvrl1更广泛,因为在肺静脉中仅发现了Eng,这可能解释了HHT1患者中动静脉畸形发生率增加的原因。此外,ACVRL1突变与第二种血管疾病家族性肺动脉高压的关联,强调了ACVRL1在该疾病所影响的远端动脉中表达的重要性。